Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_assertion type Assertion NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_head.
- NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_assertion description "[FHIT underexpression was detected in 27% of carcinoma in situ and 41% of invasive carcinoma, which suggests that it could be useful in assessing those carcinoma in situ lesions (ductal, DCIS and lobular, LCIS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_provenance.
- NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_assertion evidence source_evidence_literature NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_provenance.
- NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_assertion SIO_000772 17164758 NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_provenance.
- NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_assertion wasDerivedFrom lhgdn-20090331 NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_provenance.
- NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_assertion wasGeneratedBy ECO_0000203 NP100710.RAA66b3xZDVyB8LjtU_ey9WDKjreqftCsj_XJChS-iTwM130_provenance.